NCT06807905View on ClinicalTrials.gov

Efficiency and Biocompatibility in Hemodiafiltration Procedure

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 1, 2020

Study Completion Date

February 1, 2021

Conditions
End Stage Renal Disease on DialysisBiocompatibilityAnticoagulationHemodiafiltration
Interventions
DRUG

Heparin anticoagulation

Hemodiafiltration will be performed with heparine anticoagulation

DRUG

Citrate anticoagulation

Patient will perform dialysis with citrate anticoagulation

Trial Locations (1)

1000

University Medical Centre Ljubljana, Ljubljana, Slovenia, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT06807905 - Efficiency and Biocompatibility in Hemodiafiltration Procedure | Biotech Hunter | Biotech Hunter